This website uses cookies. By continuing to browse this website you are agreeing to our use of cookies. Find out more by reading our privacy policy. Read more
Protein delivery devices
Our ambition
In 1985, Novo Nordisk introduced the world’s first insulin pen. The insulin pen gave people with diabetes a convenient device to inject insulin several times a day. Since then, we have made extensive efforts in research and development of new delivery systems which will help people with chronic diseases manage protein therapy even better.
Our partnering focus
New injection device concepts and technologies
- Injection of soluble protein formulations
- Injection of lyophilised protein formulations
New infusion device concepts and technologies
- Subcutaneous insulin infusion
- Intravenous infusion for haemophilia therapy
New primary packaging concepts and technologies
Read more about Device R&D
Contact us
For further information please contact Device R&D Innovation Sourcing
